http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102114107-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0466 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
filingDate | 2018-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102114107-B1 |
titleOfInvention | Pharmaceutical composition for treating cancer comprising exosome like vesicle derived from natural killer cell |
abstract | The present invention relates to a pharmaceutical composition for improving or treating cancer comprising an exosome-like vesicle derived from natural killer cells as an active ingredient, wherein the vesicle can effectively suppress proliferation by targeting cancer cells. |
priorityDate | 2018-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 177.